Beta
Back to NBIS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

NBIS Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'25, NBIS's operating expenses reached a total of $212.9M USD, comprising $53.1M USD in R&D expenses and $159.9M USD in SG&A expenses, marking the highest quarterly figure in the observed period from Q1'23 to Q4'25. R&D expenses exhibited a sharp decline from $335.9M USD in Q4'23 to $25.1M USD in Q1'24, followed by a gradual recovery and acceleration to $53.1M USD by Q4'25, indicating potential cost optimizations post-2023 before renewed investment. SG&A expenses followed a similar trajectory, dropping from a peak of $988.6M USD in Q4'23 to $50.8M USD in Q1'24, then rising steadily to $159.9M USD in Q4'25, reflecting an overall volatile but upward trend in operating costs after an initial contraction, with stacked bars highlighting SG&A as the dominant component throughout.